ACADIAN ASSET MANAGEMENT LLC - EVOKE PHARMA INC ownership

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q2 2020$22,000
+450.0%
6,242
-12.2%
0.00%
Q2 2019$4,000
-93.7%
7,111
-83.1%
0.00%
Q1 2019$63,00042,1790.00%
Other shareholders
EVOKE PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 242,500$1,962,0001.69%
SOPHROSYNE CAPITAL LLC 49,000$397,0000.40%
LMR Partners LLP 23,882$187,0000.02%
GEODE CAPITAL MANAGEMENT, LLC 10,276$80,0000.00%
BlackRock Investment Management, LLC 489$4,0000.00%
MORGAN STANLEY 500$4,0000.00%
Tower Research Capital LLC (TRC) 84$1,0000.00%
VANGUARD GROUP INC 48,394$378,0000.00%
UBS AG 727$6,0000.00%
BANK OF AMERICA CORP /DE/ 33,500$271,0000.00%
View complete list of EVOKE PHARMA INC shareholders